Comparison of Effectiveness and Adverse Reactions between Isoniazid 300 mg and 400 mg in Korean Patients with Pulmonary Tuberculosis |
Park, I-Nae
(Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Ulsan College of Medicine, Asan Medical Center)
Hong, Sang-Bum (Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Ulsan College of Medicine, Asan Medical Center) Oh, Yeon-Mok (Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Ulsan College of Medicine, Asan Medical Center) Lim, Chae-Man (Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Ulsan College of Medicine, Asan Medical Center) Lee, Sang Do (Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Ulsan College of Medicine, Asan Medical Center) Koh, Younsuck (Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Ulsan College of Medicine, Asan Medical Center) Kim, Woo Sung (Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Ulsan College of Medicine, Asan Medical Center) Kim, Dong Soon (Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Ulsan College of Medicine, Asan Medical Center) Kim, Won Dong (Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Ulsan College of Medicine, Asan Medical Center) Shim, Tae Sun (Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Ulsan College of Medicine, Asan Medical Center) |
1 | Blumberg HM, Burman WJ, Chaisson RE, Daley CL, Etkind SC, Friedman LN, et al. American Thoracic Society/Centers for Disease Control and Prevention/ Infectious Diseases Society of America: treatment of tuberculosis. Am J Respir Crit Care Med 2003;167:603-62 DOI ScienceOn |
2 | Kergueris MF, Bourin M, Larousse C. Pharmacokinetics of isoniazid: influence of age. Eur J Clin Pharmacol 1986;30:335-40 DOI ScienceOn |
3 | Ahn SJ, Park SJ, Kang KW, Suh GY, Chung MP, Kim H, et al. Pharmacokinetic profiles of isoniazid and rifampicin in Korean tuberculosis patients. Tuberc Respir Dis 1999;47:442-50 DOI |
4 | World Health Organization. Treatment of tuberculosis: guidelines for national tuberculosis programme. 3rd ed. 2003 |
5 | Iseman MD. Treatment of multidrug-resistant tuberculosis. N Engl J Med 1993;329:784-91 DOI ScienceOn |
6 | Lee HS, Song HS, Lee HK, Kim KH, Chung HS, Kim CK, et al. Isoniazid metabolism and its clinical implications in Koreans. Tuberc Respir Dis 1962;12:22-37 |
7 | Ellard GA. The potential clinical significance of the isoniazid acetylator phenotype in the teatment of pulmonary tuberculosis. Tubercle 1984;65:211-27 DOI ScienceOn |
8 | Chung MP, Kim HC, Suh GY, Park JW, Kim H, Kwon OJ, et al. Pharmacokinetic study of isoniazid and rifampicin in healthy Korean volunteers. Tuberc Respir Dis 1997;44:479-92 DOI |
9 | Frieden TR, Sherman LF, Maw KL, Fujiwara PI, Crawford JT, Nivin B, et al. A multi-institutional outbreak of highly drug-resistant tuberculosis: epidemiology and clinical outcomes. JAMA 1996;276:1229-35 DOI ScienceOn |
10 | Korea Center for Disease Control and Prevention. Guidelines for the management of tuberculosis 2004 |
11 | Korea Academy of Tuberculosis and Respiratory Disease. Guidelines for the management of pulmonary tuberculosis, 1997. Tuberc Respir Dis 1997;47:1447- 53 |
12 | Armstrong AR, Peart HE. A comparison between the behavior of the Eskimos and non-Eskimos to the administration of INH. Am Rev Resp Dis 1960;81:588-94 |
13 | Harris HW, Knight PA, Selin MJ. Comparisons of isoniazid concentrations in the blood of people of Japanes and European descent. Am Rev Tuberc 1958;78: 944-8 |
14 | Peloquin CA. Pharmacology of the antimycobacterial drugs. Med Clin North Am 1993;77:1253-62 DOI |
15 | Joint Tuberculosis Committee of the British Thoracic Society. Chemotherapy and management of tuberculosis in the United Kingdom: recommendations 1998. Thorax 1998;53:536-48 DOI ScienceOn |